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Abstract
Background: Embryonic stem (ES) cells hold considerable promise as a source of cells with therapeutic potential, including
cells that can be used for drug screening and in cell replacement therapies. Differentiation of ES cells into the somatic
lineages is a regulated process; before the promise of these cells can be realised robust and rational methods for directing
differentiation into normal, functional and safe cells need to be developed. Previous in vivo studies have implicated
fibroblast growth factor (FGF) signalling in lineage specification from pluripotent cells. Although FGF signalling has been
suggested as essential for specification of mesoderm and endoderm in vivo and in culture, the exact role of this pathway
remains unclear.
Methodology/Principal Findings: Using a culture model based on early primitive ectoderm-like (EPL) cells we have
investigated the role of FGF signalling in the specification of mesoderm. We were unable to demonstrate any mesoderm
inductive capability associated with FGF1, 4 or 8 signalling, even when the factors were present at high concentrations, nor
any enhancement in mesoderm formation induced by exogenous BMP4. Furthermore, there was no evidence of alteration
of mesoderm sub-type formed with addition of FGF1, 4 or 8. Inhibition of endogenous FGF signalling, however, prevented
mesoderm and favoured neural differentiation, suggesting FGF signalling was required but not sufficient for the
differentiation of primitive ectoderm into primitive streak-like intermediates. The maintenance of ES cell/early epiblast
pluripotent marker expression was also observed in cultures when FGF signalling was inhibited.
Conclusions/Significance: FGF signalling has been shown to be required for the differentiation of primitive ectoderm to
neurectoderm. This, coupled with our observations, suggest FGF signalling is required for differentiation of the primitive
ectoderm into the germ lineages at gastrulation.
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Introduction
The fibroblast growth factor (FGF) family is a diverse family of
growth factors with 22 members identified in humans and mice
[1]. FGF signalling has been implicated in mitogenesis [2–3], cell
migration [4–5] and differentiation [6–7]. Downstream effectors of
FGF signalling include PI3 kinase [8–9], Src [10], phospholipase
Cc [9], the MAPK s, Erk (p42/44) [11–13] and p38 [9,14]. A role
for FGF signalling in mesoderm formation during embryogenesis
was first demonstrated in Xenopus laevis; using animal cap assays, it
was shown that FGFs induced ventrolateral mesoderm from an
unspecified progenitor (reviewed in [15]). Subsequently, roles for
FGF signalling in mesoderm formation, maintenance and
migration (reviewed in [9]) have been demonstrated during
embryonic development of Drosophila [16], chick [17], zebrafish
[18] and mouse [19–21].
Deletion of the FGF receptor, Fgfr1, in mice resulted in
embryonic lethality before 9.5 d.p.c. [21]. Fgfr1
2/2 embryos
showed an accumulation of cells adjacent to the primitive streak,
defective movement of cells across the primitive streak and flawed
axial organisation [21–22]. Mutant embryos were also reduced in
size compared to heterozygous littermates suggesting a defect in
epiblast proliferation. Chimaeric embryos, formed by the injection
of Fgfr1
2/2 ES cells into wildtype blastocysts, showed accumula-
tion of Fgfr1
2/2 cells adjacent to the primitive streak, a deficiency
of mutant cells within the nascent mesoderm and formation of
ectopic neural tubes comprised exclusively of mutant cells [19].
The ability of Fgfr1
2/2 ES cells to form mesoderm in
teratocarcinomas suggests that the defect in mesoderm formation
during gastrulation is a consequence of abnormal patterning and
cell migration and does not reflect a requirement for FGFR1-
mediated signalling in determining cell fate [22].
At the time of primitive streak establishment and mesoderm
formation in the embryo the expression of Fgfs 3, 4, 5, and 8 has
been detected [23–25]. Fgf4 expression was first detected within
the blastocyst [23] where it has been shown to be required for the
proliferation of the ICM [26]. Subsequently Fgf4 transcripts
localise to primitive ectoderm adjacent to the primitive streak and
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in abortive postimplantation development; embryonic lethality
occurs prior to primitive streak formation and prevents the analysis
of FGF4 function in gastrulation [27]. Fgf8 transcripts also localise
to the primitive streak [28] and are found to be expressed in cells
fated to become mesoderm and endoderm cells [26]. Disruption of
FGF8 results in a loss of FGF4 expression. In the absence of both
FGF4 and FGF8, gastrulation is severely disrupted resulting in a
loss of both embryonic mesoderm and endoderm cells [28].
Despite these observations, in vivo studies have yet to determine the
precise role of FGF signalling in mesoderm specification.
Embryonic stem (ES) cells [29–30] have been used extensively
to model the events of early mammalian embryogenesis and
characterise the roles of developmental regulators. ES cells can be
differentiated spontaneously in culture via the formation of
embryoid bodies (EBs), which are cellular aggregates formed from
ES cells and maintained in medium without the cytokine LIF [31].
Differentiation within EBs results in the formation of a diverse
range of cell types including cells representative of the three
primary germ lineages and the extraembryonic endoderm [32–
33]. The addition of an FGF signalling antagonist to EBs
demonstrated a requirement for an FGF-mediated epithelial to
mesenchymal transition (EMT) during mesoderm specification
and again in the establishment of the anterior visceral endoderm
[34]. In other differentiation regimes, using modifications of the
EB protocol or adherent culture, FGF signalling has been
implicated in the formation of the anterior definitive endoderm
[35] or maturation of neural stems cells [36] and formation of the
neural lineages [34].
ES cells can be differentiated into a uniform population of
primitive ectoderm-like cells (early primitive ectoderm-like; EPL) in
response to medium conditioned by the human hepatocellular
carcinoma cell line HepG2 [37–38]. The morphology, differenti-
ation potential, cytokine responsiveness and kinetics of gene
expression of EPL cells are consistent with the formation of an in
vitro equivalent of the embryonic primitive ectoderm, or epiblast
[37–39]. Primitive ectoderm is an obligatory intermediate in
pluripotent cell differentiation in vivo and is the immediate
progenitor ofthegermlineagesat gastrulation. Although a primitive
ectoderm equivalent formsduringEScelldifferentiationit ispresent
withothercellpopulations,mostnotablycellsoftheextraembryonic
endoderm [38,40]. These cells act as a source of endogenous
signalling and preclude determination of direct or indirect action of
exogenously added growth factors. EPL cells form without the
concomitant formation of extraembryonic endoderm or other
contaminating cell populations, making them an attractive system
for the characterisation of growth factor activity duringgastrulation.
EPL cells have been used successfully to define the roles of cell:cell
contact, mesoderm suppression and c-secretase in lineage choice
from pluripotent cells in culture [41–42].
In this report we have characterised the role of FGF signalling
in EPL cell differentiation and establishment of mesoderm. The
use of an FGF signalling inhibitor confirmed a requirement for
FGF signalling in the formation of primitive streak-like interme-
diates from EPL cells and suggests a role for FGF signalling in
epiblast maturation. However, the addition of FGFs 1, 4 and/or 8
to EPL cells in culture and in the absence of other inductive
activities, was unable to induce the formation of primitive streak-
like intermediates even when present at 250 ng/mL. Similarly, we
were unable to demonstrate a role for FGFs 4 or 8 in enhancing
differentiation induced by BMP4 or altering the sub-type of
mesoderm formed in response to BMP4. Together these data
suggest that FGF signalling is required for the loss of pluripotence
and maturation of primitive ectoderm to a cell able to respond to
differentiation-inducing signals, an essential step in establishing the
primitive streak and forming primitive streak-like intermediates.
Results
EPL cells express Fgfr1, 2, 3 and 4
FGF signalling is mediated through one of 4 tyrosine kinase
receptors, FGFR1-4. The expression of these genes in EPL cells
was determined by RT-PCR. EPL cell aggregates were generated
by culturing of D3 ES cells in 50% MEDII [38] for 3 days in
suspension and analysed using gene specific primers. A band of the
expected size (Table 1) was observed for all FGF receptors in day 3
EPL cells (Figure 1). This is consistent with a previous study
showing the expression of Fgfr1 and Fgfr2 transcripts in the
embryonic epiblast [43].
FGF signalling is required for the formation of primitive
streak-like intermediates from primitive ectoderm
Previous reports have suggested that inhibition of endogenous
FGF signalling during ES cell differentiation within EBs results in
disruption of the EMT that occurs with mesoderm specification
and a reduction in anterior visceral endoderm formation [34]. In
this report we differentiated EPL cells in serum-containing
medium supplemented with PD173074. PD173074 is a well-
characterised competitive inhibitor of FGFR1 that complexes with
the kinase domain of the receptor. PD173074 acts to inhibit
autophosphorylation of the receptor and receptor kinase activity;
the IC50 for these activities is 1 to 5 nM and 25 nM respectively
[44–45]. PD173074 was also reported to inhibit FGFR 2 [45], 3
[45–46] & 4 [47].
EPL cells, formed as aggregates, were transferred on day 3 to
serum-containing differentiation medium supplemented with
10 nM, 25 nM, 50 nM and 75 nM PD173074 or with
0.00075% DMSO. Aggregates were maintained in this medium
for 72 hours, after which they were seeded individually into 2 mL
wells containing serum-free medium and allowed to differentiate
for a further 6 days. On day 12 adherent aggregates were scored
for the presence of beating cardiomyocytes, visible red blood and
neural extensions.
Aggregates differentiated in serum-containing medium without
PD173074 formed mesoderm efficiently (58–72% forming cardio-
myocytes and 25–45% of aggregates forming visible red blood
cells; Figure 2A–B) and few neural extensions (,5%; Figure 2A–
B). Addition of 10 (data not shown) and 25 nM PD173074 resulted
in differentiation outcomes indistinguishable from the control
(Figure 2A). In contrast, addition of 50 nM PD173074 resulted in
a significant decrease in the number of aggregates containing
beating cardiomyocytes and visible red blood cells (1% and 0%
respectively, p,0.05; Figure 2B) accompanied by a marked
increase in the number of aggregates containing neural extensions
(87%, p,0.05; Figure 2B). A similar decrease in mesoderm
differentiation was observed in aggregates cultured in 75 nM
PD173074. Similarly, reduced mesoderm (cardiomyocytes and
visible red blood cells) and increased neural formation was seen
when 50 and 75 nM PD173074 was added to aggregates
differentiated in serum-free medium with 10 ng/ml BMP4 as
the mesoderm inducer (Figure 2C).
RNA was extracted from treated aggregates on day 12 and
analysed for expression of b-globin genes (b-h1, b-major) and neural
markers (Sox1, Mash1) via RT-PCR. PD173074 did not appear to
affect the expression levels of these markers at 25 nM. At 50 and
75 nM PD173074, however, reduced globin gene expression and
increased neural marker gene expression was observed (Figure 3A).
Immunofluorescence analysis of these cells with bIII-tubulin and
FGFs in Gastrulation
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Gene Sequence 59 -.39 Size of PCR product (bp) No. of PCR cycles
b-h1 - F CAC TGT GAC AAG CTT CAT GTG G 87 26
b-h1 - R CCT TGG CAA AAT GAG TAG AAA GG
b-major - F ACA GGC TGC CTT CCA GAA GG 115 30
b-major - R ACT GAC AGA TGC TCT CTT GGG
Sox1 - F GACTTGCAGGCTATGTACAACATC 171 26
Sox1 - R CCTCTCAGACGGTGGAGTTATATT
Mash1 - F TAGCCCAGAGGAACAAGAGC 86 26
Mash1 - R CTGCTTCCAAAGTCCATTCC
Fgfr1 - F CAAGAAGAGCGACTTCCATAGCCAGATG 230 35
Fgfr1 - R AGACCAGTCTGTCTCGTGGCAGC
Fgfr2 - F CGCCTGTGAGAGAGAGAAGGAGATCACG 265 35
Fgfr2 - R GCTGTTGAGGACAGACGCGTTGTT
Fgfr3 - F AAACTGATGAGGCTGGCAGCGTG 326 35
Fgfr3 - R GTGTCAGCCGGGTCCTGGATAGC
Fgfr4 - F GTACCCTCGGACCGCGGCACATAC 243 35
Fgfr4 - R GCCGAAGCTGCTGCCGTTGATG
GAPDH - F CTTCACCACCATGGAGAAGGC 236 18
GAPDH - R GGCATGGACTGTGGTCATGAG
Brachyury (T) - F TGCTGCCTGTGAGTCATAAC 143 26
Brachyury (T) - R GCCTCGAAAGAACTGAGCTC
Wnt3 - F TCCACTGGTGCTGCTATGTC 138 26
Wnt3 - R CCTGCTTCTCATGGGACTTC
Bmp4 - F AGGAGGAGGAGGAAGAGCAG 118 26
Bmp4 - R CCTGGGATGTTCTCCAGATG
Mixl1 - F CTTCCGACAGACCATGTACCC 145 30
Mixl1 - R GATAAGGGCTGAAATGACTTCCC
Flk1 - F CACCTGGCACTCTCCACCTTC 240 30
Flk1 - R GATTTCATCCCACTACCGAAAG
Snail1 - F GCCGGAAGCCCAACTATAGC 64 30
Snail1 - R TAGGGCTGCTGGAAGGTGAA
Snail2 - F GCTCCTTCCTGGTCAAGAAACA 117 30
Snail2 - R TGACAGGTATAGGGTAACTTTCATAGAGA
Cer1 - F AGAGGTTCTGGCATCGGTTC 229 26
Cer1 - R GAGCAGAAGCTGTGGGCATC
Chrd - F AGACCAAGCCTCAGCGGAAG 155 30
Chrd - R GGTACCAACATTCAGGAACAGC
Mesp1 - F TCGTTCCAGTACGCAGAAACAGC 179 26
Mesp1 - R TCAGACAGGGTGACAATCATCCG
Fgf4 - F ACTACCTGCTGGGCCTCAA 169 32
Fgf4 - R ACTCCGAAGATGCTCACCAC
Fgf8 - F TCCGGACCTACCAGCTCTAC 143 26
Fgf8 - R TCGGACTCTGCTTCCAAAAG
Rex1 - F TGC CTC CAA GTG TTG TCC C 118 qPCR
Rex1 - R ATT CAT GTT GTC TTA GCT GCT TCC
Fgf5 - F CTG CAG ATC TAC CCG GAT G 169 qPCR
Fgf5 - R TAA ATT TGG CAC TTG CAT GG
Oct4 - F CCC AGG CCG ACG TGG 66 qPCR
Oct4 - R GAT GGT GGT CTG GCT GAA CAC
doi:10.1371/journal.pone.0012555.t001
FGFs in Gastrulation
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staining with bIII-tubulin was observed at 50 and 75 nM
PD173074 (Figure. 3B) while reduced cardiac troponin 1 staining
was observed at 75 nM PD173074 (Figure. 3C).
These data suggested that inhibition of endogenous FGF
signalling resulted in a reduction in mesoderm formation. The
effect of PD173074 on the formation of primitive streak
intermediates and nascent mesoderm was determined by RT-
PCR. EPL cells differentiated in the presence of 25, 50 and 75 nM
PD173074 were collected after 24, 48, 72 and 96 hours and
analysed for expression of primitive streak (T, Mixl1, Wnt3),
anterior (Chrd, Cer1) or posterior (Mesp1) streak, mesoderm (Bmp4,
Flk1) and EMT (Snail1, Snail2) markers. The presence of 25 nM
PD173074 did not prevent the expression of primitive streak and
mesoderm markers in differentiating EPL cells. In contrast, we
noted a precocious expression of primitive streak markers such as
T, Bmp4 and Mixl1 and a decrease of anterior primitive streak
markers Cer1 and Chrd (Figure 2D). Differentiation in 50 and
75 nM PD173074, however, resulted in a marked reduction in the
expression of all gene markers, suggesting that commitment to
primitive streak intermediate, during early mesoderm formation, is
inhibited in the presence of PD173074 (Figure 2D). The reduction
in marker expression appeared to be dose dependent.
Collectively, these data indicate a requirement for FGF
signalling in the differentiation of the primitive ectoderm to
primitive streak intermediates.
FGFs are unable to induce mesoderm from EPL cells in
vitro
There is little information on the ability of exogenously added
FGFs to exert an effect on pluripotent cell differentiation in
culture. This may reflect deficiencies in the assay systems used to
date or a lack of inductive capacity associated with this growth
factor family. Here, EPL cell aggregates were cultured in serum-
free differentiation medium supplemented with 10 ng/mL and
25 ng/mL of FGF1, 4 or 8 for 72 hours. Alternatively, EPL cell
aggregates were cultured in serum-free differentiation medium
containing a saturating concentration of FGF1, 4 or 8 (250 ng/
mL) for 72 hours to ensure that any effect of the factors in this
assay would be detected. After treatment, individual aggregates
were transferred into 2 mL wells containing unsupplemented
serum-free medium, allowed to differentiate and scored for the
presence of beating cardiomyocytes, visible red blood and neural
extensions (Figure 4A–C). EPL cells maintained in serum-free
differentiation medium formed neurons efficiently (65% to 85%)
when compared to controls cultured in serum-containing medium
(,8%). The formation of beating cardiomyocytes in serum-free
aggregates (3% to 30%), however, was significantly lower than
serum containing controls (.60%). Also, although red blood cells
were readily detected in serum containing controls, no blood
formation was detected in aggregates cultured in serum-free
differentiation medium. These data suggest that mesoderm is
formed inefficiently in aggregates cultured in serum-free differen-
tiation medium; these aggregates provide an ideal assay system for
detecting the inductive capacity of FGFs 1, 4 and 8 in culture.
Aggregates cultured in FGFs 1, 4 or 8, however, showed
differentiation outcomes indistinguishable from controls cultured
in serum-free differentiation medium (Figure 4A–C).
In addition to differentiation outcome, EPL cells differentiated
in the presence of FGFs 4 and 8 were analysed for the expression
of a panel of marker genes of the primitive streak, mesoderm and
EMT, as for Figure 2D. As expected from the results of the
differentiation assay, gene expression analysis did not show any
observable differences in differentiation markers in cells differen-
tiated in the presence of either FGF4 or 8 when compared to
controls (Figure 3C&4E).
Within the primitive streak a number of FGF family members
are present suggesting the possibility that these factors act
synergistically to induce mesoderm formation within this environ-
ment. To address this possibility, EPL cell aggregates were
cultured in serum-free differentiation medium supplemented with
a combination of FGFs 1, 4 and 8 at 25 ng/mL each. The
treatment with 25 ng/mL of FGFs 1, 4 and 8 in combination did
not yield any significant differences in the formation of beating
cardiomyocytes, visible red blood or neural extensions when
compared to the serum-free controls. This further supports the
notion that the FGFs are unable to induce mesoderm from EPL
cells in culture (Figure 4D).
Can FGF signalling specify nascent mesoderm formed
during EPL cell differentiation in culture?
Previous studies in lower vertebrates and insects have suggested
that FGF signalling is required for mesoderm induction [48–50].
In mouse, it has been suggested these factors act to specify
mesoderm and/or endoderm subtypes during gastrulation [34–
35]. Here, we analysed the ability of FGF signalling to alter the
mesoderm subtypes formed from EPL cells induced to form
mesoderm in the presence of BMP4 [51–52]. BMP4 is a
mesoderm inducer that typically enriches the formation of more
posterior mesoderm populations, such as primitive blood, during
pluripotent cell differentiation [34,53–54]. If FGF signalling was
acting to specify nascent mesoderm we might expect to observe
changes in the relative frequencies of beating cardiomyocytes or
visible red blood cells, or a loss of these outcomes and the
formation of a ‘non-recognisable’ mesoderm.
EPL cell aggregates were cultured in serum-free differentiation
medium supplemented with 10 ng/mL of BMP4 and 25 ng/mL
of FGF4 or 8 for 72–96 hours. As for Figures 2 and 4, individual
aggregates were transferred into 2 mL wells containing unsupple-
mented serum-free medium and scored for observable differenti-
ation outcomes. The treatment of EPL cell aggregates with BMP4
resulted in morphological changes in aggregate structure; in
Figure 1. Expression of Fgfr1-4 in EPL cells. EPL cells (EPL3) were
analysed by non-quantitative RT-PCR for the expression of Fgfr1-4.
Negative controls contained no cDNA (-DNA) or no reverse transcrip-
tase (-RT) was added during cDNA synthesis. Positive controls include
10.5 d.p.c. embryo tissue (D10.5 embryo) and day 9 cell aggregates
cultured in serum (D9 ESEB). Expression of Fgfr1-4 was detected in D9
ESEB and EPL cell aggregates.
doi:10.1371/journal.pone.0012555.g001
FGFs in Gastrulation
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packed with ruffled edges (data not shown). This morphology was
not altered by the addition of 25 ng/mL of FGFs 4 or 8. As before,
aggregates cultured in serum-free differentiation medium formed
neurons preferentially, with 62% of these aggregates forming
neural extensions and 26% forming beating cardiomyocytes; the
addition of FGF 4 or 8 did not alter the overall prevalence of these
differentiation outcomes. In the presence of BMP4, 50% of
aggregates contained visible red blood cells and no aggregates
formed neural extensions. Again, no significant differences in
differentiation outcomes was observed between aggregates cul-
tured in BMP4 and FGFs 4 or 8 as compared to those cultured in
BMP4 alone (Figure 5A).
We did observe variability in the mesoderm populations
induced by BMP4 during the course of this work, as illustrated
by the different outcomes seen in Figures 2C and 5A; this is
potentially related to the use of different batches of BMP4
throughout these experiments. Regardless of the subtle changes in
mesoderm produced, a consistent induction of mesoderm and
reduced ectoderm formation was observed upon BMP4 treatment.
Interpretation of our data was not affected as mesoderm outcomes
were analysed collectively.
EPL cell aggregates cultured in serum-free differentiation
medium supplemented with BMP4 and FGFs 4 and 8 were
analysed for the expression of a panel of markers of the primitive
streak, mesoderm and EMT, as for Figure 5B. EPL cell aggregates
differentiated in the presence of BMP4 showed a robust
upregulation of primitive streak (T, Wnt3, Mixl1), mesoderm
(Bmp4, Flk1) and EMT (Snail1, Snail2) markers. Cells differentiated
in BMP4 showed low expression of anterior streak genes (Cer1,
Chrd) and detectable expression of the posterior streak marker
Mesp1, suggesting the enrichment of more posterior mesoderm
populations. The addition of FGFs 4 or 8 to BMP4 treated
cultures did not alter the gene expression pattern (Figure 5B–C),
suggesting that FGF signalling was unable to alter mesoderm
specification during the differentiation of EPL cells to mesoderm.
Potentially, BMP4 induces the expression of one or more of the
FGF family members during mesoderm induction. qRT-PCR
analyses of EPL cell aggregates treated with BMP4 and FGFs 4 or
8 for 2 days revealed a significant upregulation of the Fgf8
transcripts in the aggregates cultured in BMP4 (Figure 5C). No
equivalent upregulation of Fgf4 was seen (Figure 5B, data not
shown).
FGF signalling affects ES cell pluripotency and epiblast
maturation
FGF 2 has been previously reported to maintain pluripotency in
human ES cells [55–57], suggesting a role in pluripotent cell
regulation. The effect of blocking FGF signalling on the regulation
of pluripotence during EPL cell differentiation was investigated.
Cells differentiated in PD173074 (25, 50 and 75 nM) were
analysed on days 1 and 4 for the expression of pluripotent (Oct4),
ICM (Rex1) and primitive ectoderm (Fgf5) markers by qRT-PCR.
Oct4 and Rex1 expression was significantly higher in cells that had
been differentiated for 4 days in the presence of PD173074 when
compared with DMSO-containing controls (Fig. 6). Conversely,
significantly fewer Fgf5 transcripts were detected after 24 hours in
cells differentiated in PD173074 at 50 and 75 nM when compared
to day 1 controls containing DMSO only (Fig. 6); expression of
Fgf5 remained low on day 4 in PD173074 treated cells.
Discussion
FGF signalling is required for differentiation to form
mesoderm from EPL cells
Previous studies have implicated the involvement of FGF
signalling in the formation of a receptive pluripotent intermediate
from ES cells [58], mesoderm and endoderm in the primitive
streak and in the establishment of the ectoderm lineage [19,28].
Specifically, FGF signalling has been implicated in the migration
of cells through the primitive streak [28] and in neural
specification via activation of the ERK signalling pathway [13].
We have exploited a model of the primitive ectoderm, EPL cells,
to analyse the effect of FGF signalling in the differentiation of this
cell population. Inhibition of endogenous FGF signalling during
EPL cell differentiation resulted in the inhibition of mesoderm
formation and decreased expression of early primitive streak
markers such as brachyury. During gastrulation, brachyury expression
initiates in the epiblast and precedes streak formation [59]
suggesting that the first requirement for FGF signalling in
gastrulation may be prior to primitive streak formation and
lineage specification.
At higher concentrations of inhibitor a total loss of primitive
streak markers was observed; the ability of the inhibitor to suppress
primitive streak was dose dependent. In another study, Willems
and Leyns [34] observed expression of brachyury in differentiating
ES cells in the presence of FGF inhibition by SU5402. Potentially
the concentration of SU5402 used, or the efficiency of this
inhibitor, was unable to prevent completely the formation of the
primitive streak intermediates and revealed a later requirement for
FGF signalling in facilitating EMT.
FGF signalling is unable to induce or pattern mesoderm
Increasing the concentration of FGFs during EPL cell
differentiation, by adding exogenous FGFs 1, 4 or 8, failed to
affect the outcomes of differentiation or the gene expression
profiles observed during differentiation. Coupled with the
requirement for endogenous FGF signalling, this suggests that
FGF signalling is required but not sufficient for the formation of
the mesoderm lineage from EPL cells. This is consistent with the
ability of FGF2 to maintain and not differentiate human ES cells
in culture [55,60–62] and the role of FGF signalling in
differentiation of ES cells to neural, but not mesoderm lineages,
in culture [63]. Neural differentiation was observed from cells
cultured in the presence of the FGF signalling inhibitor in the
differentiation assays presented here. These cells were also
Figure 2. Differentiation outcomes and gene expression from EPL cells cultured in an FGF signalling inhibitor. (A) Differentiation
outcomes from EPL cells cultured in serum-containing medium supplemented with 25 nM PD173074. n=7. (B) Differentiation outcomes from EPL
cells cultured in serum-containing medium supplemented with 50 and 75 nM PD173074. Addition of PD173074 resulted in a significant decrease in
cardiomyocytes and blood and a significant increase in neuron formation. n=3. * indicates a significant increase (p,0.05) when compared to serum
+ DMSO. # indicates a significant decrease (p,0.05) when compared to serum + DMSO. (C) Scored differentiation outcomes of EPL cells cultured in
serum-free medium supplemented with 10 ng/ml BMP4 and 50 or 75 nM PD173074. Addition of PD173074 at 50 and 75 nM concentrations had
significantly reduced cardiomyocytes (p,0.05) and increased neuron (p,0.05) formation. * indicates a significant increase when compared to serum-
free medium containing 10 ng/ml BMP4; p,0.05. # indicates a significant decrease when compared to serum-free medium containing 10 ng/ml
BMP4; p,0.05. n=3. (D) Gene expression of EPL cells cultured in serum-containing media supplemented with 0.00025% DMSO, 25, 50 or 75 nM of
PD173074 for 1, 2, 3 and 4 days was analysed using RT-PCR. n=3. A representative result is shown.
doi:10.1371/journal.pone.0012555.g002
FGFs in Gastrulation
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activity, that we propose will compensate for FGF signalling and
enforce differentiation of the cells to the ectoderm. This is
consistent with Willems and Leyns [34], who reported a
comparable upregulation of the neural marker Sox1 in ES cells
differentiated in the presence of FGF inhibitor and serum.
Alternatively, we considered that FGF signalling may be
involved in the specification of mesoderm subtypes during
differentiation. The addition of FGFs 4 or 8 in combination with
BMP4, however, failed to change the differentiation outcome or
gene expression pattern of differentiation. This observation is
similar with a previous study demonstrating that FGF2 was unable
to synergistically induce mesoderm with BMP4 [64]. Collectively,
these observations suggest that FGF signalling was unable to
induce, enhance or pattern mesoderm formation from EPL cells in
culture.
BMP4 induction of primitive streak intermediates and meso-
derm resulted in an increase in Fgf8, but not Fgf4, expression. FGF
signalling has been implicated in several processes in gastrulation,
including a role in regulating E-cadherin expression and promoting
the migration of nascent mesoderm in the primitive streak [28].
The induction of Fgf8 by BMP4 during primitive streak
intermediate and mesoderm formation may serve to ensure all
cells are exposed to FGF signalling and susceptible to differenti-
Figure 3. Inhibition of FGF signalling results in increased neurectoderm formation. (A) (Left) Gene expression of day 9 cells cultured in
serum-free medium supplemented with 25 or 250 ng/ml of FGF4 or 8. (Right) Gene expression of day 9 cells cultured in serum-containing medium
supplemented with 25, 50 or 75 nM of PD173074. Treatment of cells with 50 and 75 nM of PD173074 resulted in reduced expression of globin genes
(b-h1, b-major) and increase expression of neural markers (Sox1, Mash1) as compared to controls. n=3. A representative result is shown. (B) EPL cells
were cultured in serum-containing medium supplemented with 25, 50 or 75 nM PD173074 for 4 days and transferred into serum-free medium till day
9. Day 9 cells were stained for bIII-tubulin. Increased bIII-tubulin staining was observed with treatment of PD173074 at 50 and 75 nM concentrations.
(C) Day 9 cells showed reduced protein expression of cardiac troponin 1 upon treatment of PD173074 at 75 nM. (B–C) No fluorescence was detected
in the secondary antibody only controls (data not shown).
doi:10.1371/journal.pone.0012555.g003
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PLoS ONE | www.plosone.org 7 September 2010 | Volume 5 | Issue 9 | e12555Figure 4. Differentiation outcomes and gene expression of EPL cells cultured in FGFs 1, 4 or 8, or a combination FGFs 1, 4 and 8. (A–
D) Differentiation outcomes for EPL cells cultured in serum-free medium supplemented with 10, 25 or 250 ng/mL of FGFs 1, 4 or 8, or a combination
of FGFs 1, 4 and 8 at 25 ng/mL, are statistically similar to their respective serum-free controls. Serum-containing controls have significantly increased
cardiomyocytes or blood formation and significantly lower neuron formation compared to the serum-free controls. * indicates a significant increase
(p,0.05) when compared to serum-free medium, # indicates a significant decrease (p,0.05) compared to serum-free medium. n=3. (E) Gene
expression of EPL cells cultured in serum-free medium supplemented with 25 or 250 ng/mL of FGFs 4 or 8 for 1, 2, 3 and 4 days was analysed using
RT-PCR. n=3. A representative result is shown.
doi:10.1371/journal.pone.0012555.g004
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migration in primitive streak intermediates committed to meso-
derm.
A role for FGF signalling prior to lineage specification
Recently,FGFsignallinghasbeenreportedtobeinvolvedinboth
endoderm and neurectoderm formation [13,35]. The requirement
for FGF signalling intheformationofprimitive streak-intermediates
shown here, and in neural specification via ERK activation [13] is
consistent with a model that places FGF signalling upstream of all
germ lineage formation at gastrulation. An increased expression of
Oct4 and Rex1 was seen after 4 days of EPL cell differentiation in
FGF inhibitors when compared to untreated controls. Conversely,
in treated populations the expression of Fgf5 expression was
significantly lower when compared to untreated controls. These
data suggest that a proportion of the cell populationdifferentiatedin
the presence of FGF signalling inhibitors retains pluripotency and
fails to express high levels of Fgf5, implicating FGF signalling in loss
of pluripotency and epiblast progression. Coupled with the reduced
capability of cells to differentiate to primitive streak-like interme-
diates, these data suggest that FGF signalling in the epiblast
functions to make primitive ectoderm competent to differentiate.
This is consistent with recent observations that FGF signalling
influences primitive endoderm and epiblast development of ICM
cells [65], stabilises the epiblast state in epiSCs [66] and the
previously proposed role for ERK signalling in ES cell differenti-
ation [58]. As PD173074 inhibits FGF signalling competitively by
acting on FGF receptors, the reduction of Fgf5 expression may also
indicate the presence of positive feedback by FGF signalling on Fgf5
expression. From these data it is tempting to speculate that
increasing levels of Fgf5 in the primitive ectoderm may reach a
point that triggers the loss of pluripotency and adoption of a cell
state receptive to inductive signals that function to specify the
formation of the germ lineages, thereby ensuring the coordinated
and complete differentiation of pluripotent cells during gastrulation.
Using EPL cells as a model system has allowed us to show that
FGF signalling is necessary but not sufficient for the formation of
the primitive streak lineages in vitro and suggest a role for FGF
signalling upstream of lineage specification in epiblast maturation
prior to gastrulation.
Materials and Methods
Verification of biological activities of FGFs 1, 4, 8 and the
FGFR inhibitor PD173074
Previous studies have shown a proliferative response in rat lens
epithelial cells when treated with 250 ng/mL and 25 ng/mL of
FGF1 and FGF2 respectively [67–68]. This assay was used to
show that the purchased FGFs 1, 4 and 8 (R&D Systems) and the
FGF receptor inhibitor PD173074, were biologically active. Lens
epithelial explants from day 3 Wistar rats were cultured in the
presence of 250 ng/mL of FGF1, 4 and 8 or 250 ng/mL of FGF1
Figure 5. Addition of FGF4 or 8 does not alter the differentiation outcomes and gene expression from EPL cells differentiating in
response to BMP4. (A) EPL cells were cultured in serum-free medium supplemented with 10 ng/mL BMP4 and 25 ng/mL FGFs 4 or 8 and the
outcomes of differentiation scored. Significantly more BMP4-treated EPL cell aggregates formed blood, and fewer formed neural extensions, compared
to serum-free controls. Differentiation outcomes of cell aggregates treated with BMP4 and FGF4 or FGF8 were statistically similar to the BMP4-treated
controls. * indicates a significant increase when compared to serum-free medium; p,0.05. # indicates a significant decrease when compared to serum-
free medium; p,0.05. n=3. (B) Gene expression of EPL cells cultured in serum-free medium supplemented with BMP4 and FGFs 4 or 8 for 1, 2, 3 and 4
days was analysed using RT-PCR. EPL cells cultured in BMP4 showed increased gene expression of primitive streak and mesoderm markers (T, Mixl1,
Wnt3, Bmp4, Flk1),anterior (Cer1, Chrd) andposterior(Mesp1) streakmarkers, EMT(Snail1, Snail2). No changesin gene expression were observed with the
further addition of 25 ng/mL of FGFs 4 or 8. n=3. A representative result is shown. (C) EPL cells differentiated as for (B) for 2 days were analysed by qRT-
PCR for the expression of Fgf8. Fgf8 expression was significantly increased with addition of BMP4 when compared to serum-free controls where p,0.05.
All data were analysed relative to GAPDH and normalised to S/F controls. Error bars represent SEM. n=3.
doi:10.1371/journal.pone.0012555.g005
Figure 6. Inhibition of FGF signalling results in increased
expression of pluripotent markers. (A–C) Quantitative PCR analysis
of EPL cells cultured in serum-containing medium in the presence of 25,
50 and 75 nM PD173074 for 1 and 4 days. (A) Expression of Oct4 was
found to persist at day 4 in cultures containing PD173074 as compared
to DMSO controls (p.0.05). (B) Addition of PD173074 at 50 and 75 nM
concentrations resulted in a significant decrease in Fgf5 expression after
1 day of treatment. (C) D4 cells cultured in the presence of 25, 50 and
75 nM PD173074 showed significant increases of Rex1 as compared to
D4 DMSO controls. All data were analysed relative to GAPDH and
normalised to D1 serum + DMSO controls. Error bars represent SEM.
* indicates a significant decrease when compared to D1 serum + DMSO
controls; p,0.05. # indicates a significant increase when compared to
D4 serum + DMSO control s; p,0.05. n=3.
doi:10.1371/journal.pone.0012555.g006
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added to a final concentration of 150 mg/mL and explants
cultured for a further 8 hours. Explants were fixed and stained
with anti-BrdU antibodies conjugated with HRP enzymes as
described [67–68]. Explants treated with the FGFs had an
increased BrdU incorporation when compared to untreated
controls (Figure S1). In explants treated with both FGF1 and
PD173074, the increase in proliferating cells was less than that
seen in explants treated with FGF1 alone (Figure S1). These
findings indicate that the FGFs and the FGFR specific inhibitor to
be used in this study were biologically active.
Cell culture
ES cell line D3 [31] was used in this study. The culture,
maintenance, formation of EPLs from D3 ES cells and formulation
of the conditioned media MEDII to form EPL cells were as
described previously in [69]. For all experiments, EPL cells were
formed within cellular aggregates [70]. Briefly, a single cell
suspension of D3 ES cells was seeded at 1610
5 cells/mL in 50%
MEDII[69].Aggregateswere divided 1in2 andre-fedonday3.All
treatmentswereinitiatedusingaggregatesthathad beenmaintained
for 3 days in MEDII.
Differentiation assays
EPL cell aggregates were transferred to differentiation medium
[69] or chemically defined medium (50% DMEM, 50% Hams
F12 (Invitrogen) supplemented with 1 x insulin transferring sodium
selenite (Sigma), 0.1 mM b-mercaptoethanol (b-ME; Sigma),
50 u/mL penicillin (Chemicon), 50 mg/mL streptomycin (Chemi-
con)) supplemented with FGFs, BMP4 and/or PD173074, as
described in the text, and cultured for a further 3 days. At this
point, aggregates were transferred from suspension culture to
adherent culture. Aggregates were placed individually into 2 mL
tissue culture wells which had been pre-treated with gelatin and
contained chemically defined medium [69]. Aggregates were
scored on day 6 for the presence of three morphologically
distinctive cell types, beating cardiomyocytes, visible red blood or
neural extensions as described previously [41–42]; cells with
neural projections have been shown previously to express bIII-
tubulin and NeuN [70]. Generally, for each experimental
condition 24 individual wells with randomly selected cellular
aggregates were scored and experiments were repeated a
minimum of three times. Data collected was analysed statistically
with a two-tailed student’s t-test.
Gene expression analysis
RT-PCR. Total cytoplasmic RNA was extracted using Trizol
reagent (Invitrogen). cDNA was synthesised using M-MLV
Reverse Transcriptase (Promega). For all PCR reactions in this
study, reaction tubes contained a final volume of 25 mL containing
1 ng/mL each of forward and reverse primers, 1 x concentration of
GoTaqH Green Master Mix (Promega) and cDNA. Samples were
heated to 95uC for 2 minutes before cycled according to table 1 at
95uC for 30 s, 60uC for 30 s and 72uC for 30 s before a 5 minute
final extension step at 72uC on an MJ Research thermocycler. A
list of primer sequences, number of amplification cycles used and
expected amplicon size are listed in Table 1.
qRT-PCR. RNAwasisolatedandcDNA synthesisedasforRT
PCR. qPCR reaction mix consisted of 1X Absolute blue QPCR
SYBR Green Mix (Thermo Scientific) with 200 nM of forward and
reverse primers (GAPDH & Fgf8; Table 1). Reactions were amplified
on an MJ research thermocycler with a Chromo4 Continuous
Fluorescence Detection system (MJ Research). The raw data was
analysed using the Q-Gene software package [71–72].
Immunocytochemistry. EPL cells aggregates were cultured
as described in the differentiation assays but were allowed to
adhere to 0.2% gelatin treated glass coverslips. The adherent cells
were fixed with 4% paraformaldehyde 6 days after seeding onto
coverslips and washed with PBS. Fixed cells were permeabilised
with 0.25% Triton X-100 in PBS for 20 minutes. Coverslips were
blocked with 0.5% Tween20, 1% FBS in PBS for 30 minutes.
Primary antibody staining was performed with mouse monoclonal
anti bIII-tubulin (Sigma, T8578) and anti cardiac troponin 1
(Abcam, ab19615) overnight in a humidified chamber. Secondary
antibody staining was performed with Alexa FluorH 488 rabbit
anti-mouse IgG (Invitrogen, A11059).
Supporting Information
Figure S1 FGF 1, 4 or 8 was able to induce proliferation in rat
lens epithelial cells. (A-E): Rat lens epithelial explants treated with
(A) 250 ng/ml FGF1, (B) 250 ng/ml FGF4, (C) 250 ng/ml FGF8,
(D) 250 ng/ml FGF1 with 25 nM PD173074 or (E) untreated. (F):
Average of 6 randomly counted 200-by-200 micron quadrants
across all treatments and control explants. A two-tailed student’s t-
test demonstrates a significant increase in BrdU incorporation in
all treatments when compared to untreated controls. FGF4 and
FGF8 were less effective in inducing cell proliferation (32% and
30% respectively) than FGF1 (44%). Inclusion of 25 nM
PD173074 significantly inhibited (p,0.05) proliferation induced
by 250 ng/ml FGF1. * indicates a significant increase when
compared to controls where p,0.05. # indicates a significant
decrease when compared to 250 ng/ml Fgf1 where p,0.05.
Found at: doi:10.1371/journal.pone.0012555.s001 (5.34 MB TIF)
Acknowledgments
We thank Dr. Mirella Dottori for Anti bIII-tubulin antibody, Dr. Mary
Familari and Ms. Charlotte Yap for technical discussions, Ms. Natasha
Dodge for technical assistance and Dr. Edwin Wong for critical reading of
the manuscript.
Author Contributions
Conceived and designed the experiments: ZZ RdI PDR JR. Performed the
experiments: ZZ RdI. Analyzed the data: ZZ JR. Contributed reagents/
materials/analysis tools: RdI PDR. Wrote the paper: ZZ JR.
References
1. Ornitz D, Itoh N (2001) Fibroblast growth factors. Genome Biol 2:
3005.3001–3005.3012.
2. Wang J, Goldfarb M (1997) Amino acid residues which distinguish the mitogenic
potentials of two FGF receptors. Oncogene 14: 1767–1778.
3. Wang J, Gao G, Goldfarb M (1994) Fibroblast growth factor receptors have different
signaling and mitogenic potentials. Molecular and Cellular Biology 14: 181–188.
4. Sutherland D, Samakovlis C, Krasnow M (1996) branchless encodes a
Drosophila FGF homolog that controls tracheal cell migration and the pattern
of branching. Cell 87: 1091–1101.
5. Montell D (1994) Moving right along: regulation of cell migration during
Drosophila development. Trends Genet 10: 59–62.
6. Fisher L (1997) Neural Precursor Cells: Applications for the Study and Repair of
the Central Nervous System. Neurobiology of Disease 4: 1–22.
7. Lin H, Xu J, Ischenko I, Ornitz D, Halegoua S, et al. (1998) Identification of the
Cytoplasmic Regions of Fibroblast Growth Factor (FGF) Receptor 1 Which Play
Important Roles in Induction of Neurite Outgrowth in PC12 Cells by FGF-1.
Molecular and Cellular Biology 18: 3762–3770.
8. Chen Y, Li X, Eswarakumar V, Seger R, Lonai P (2000) Fibroblast growth
factor (FGF) signaling through PI 3-kinase and Akt/PKB is required for
embryoid body differentiation. Oncogene 19; 3750-3756.
9. Bottcher R, Niehrs C (2005) Fibroblast growth factor signaling during early
vertebrate development. Endocrine reviews 26: 63–77.
FGFs in Gastrulation
PLoS ONE | www.plosone.org 11 September 2010 | Volume 5 | Issue 9 | e1255510. Zhan X, Plourde C, Hu X, Friesel R, Maciag T (1994) Association of fibroblast
growth factor receptor-1 with c-Src correlates with association between c-Src
and cortactin. Journal of Biological Chemistry 269: 20221–20224.
11. LaBonne C, Burke B, Whitman M (1995) Role of MAP kinase in mesoderm
induction and axial patterning during Xenopus development. Development 121:
1475.
12. Umbhauer M, Marshall C, Mason C, Old R, Smith J (1995) Mesoderm
induction in Xenopus caused by activation of MAP kinase. Nature 376: 58–62.
13. Stavridis M, Lunn J, Collins B, Storey K (2007) A discrete period of FGF-
induced Erk1/2 signalling is required for vertebrate neural specification.
Development 134: 2889.
14. Maher P (1999) p38 Mitogen-activated Protein Kinase Activation Is Required
for Fibroblast Growth Factor-2-stimulated Cell Proliferation but Not Differen-
tiation. Journal of Biological Chemistry 274: 17491–17498.
15. Isaacs H (1997) New perspectives on the role of the fibroblast growth factor
family in amphibian development. Cellular and Molecular Life Sciences (CMLS)
53: 350–361.
16. Beiman M, Shilo B, Volk T (1996) Heartless, a Drosophila FGF receptor
homolog, is essential for cell migration and establishment of several mesodermal
lineages. Genes & Development 10: 2993–3002.
17. Mitrani E, Gruenbaum Y, Shohat H, Ziv T (1990) Fibroblast growth factor
during mesoderm induction in the early chick embryo. Development 109: 387.
18. Griffin K, Patient R, Holder N (1995) Analysis of FGF function in normal and
no tail zebrafish embryos reveals separate mechanisms for formation of the trunk
and the tail. Development 121: 2983–2994.
19. Ciruna B, Schwartz L, Harpal K, Yamaguchi T, Rossant J (1997) Chimeric
analysis of fibroblast growth factor receptor-1 (Fgfr1) function: a role for FGFR1
in morphogenetic movement through the primitive streak. Development 124:
2829.
20. Dell’Era P, Ronca R, Coco L, Nicoli S, Metra M, et al. (2003) Fibroblast growth
factor receptor-1 is essential for in vitro cardiomyocyte development. Circulation
research: Am Heart Assoc. pp 414–420.
21. Yamaguchi T, Harpal K, Henkemeyer M, Rossant J (1994) fgfr-1 is required for
embryonic growth and mesodermal patterning during mouse gastrulation.
Genes & Development 8: 3032–3044.
22. Deng C, Wynshaw-Boris A, Shen M, Daugherty C, Ornitz D, et al. (1994)
Murine FGFR-1 is required for early postimplantation growth and axial
organization. Genes & development 8: 3045–3057.
23. Niswander L, Martin G (1992) Fgf-4 expression during gastrulation, myogenesis,
limb and tooth development in the mouse. Development. pp 755–768.
24. Haub O, Goldfarb M (1991) Expression of the fibroblast growth factor-5 gene in
the mouse embryo. Development. pp 397–406.
25. Ohuchi H, Yoshioka H, Tanaka A, Kawakami Y, Nohno T, et al. (1994)
Involvement of androgen-induced growth factor (FGF-8) gene in mouse
embryogenesis and morphogenesis. Biochemical and biophysical research
communications 204: 882.
26. Yamaguchi TP, Rossant J (1995) Fibroblast growth factors in mammalian
development. Curr Opin Genet Dev 5: 485–491.
27. Feldman B, Poueymirou W, Papaioannou VE, DeChiara TM, Goldfarb M
(1995) Requirement of FGF-4 for postimplantation mouse development. Science
267: 246–249.
28. Ciruna B, Rossant J (2001) FGF signaling regulates mesoderm cell fate
specification and morphogenetic movement at the primitive streak. Develop-
mental cell 1: 37–49.
29. Martin G (1981) Isolation of a pluripotent cell line from early mouse embryos
cultured in medium conditioned by teratocarcinoma stem cells. Proceedings of
the National Academy of Sciences 78: 7634–7638.
30. Evans M, Kaufman M (1981) Establishment in culture of pluripotential cells
from mouse embryos. Nature 292: 154–156.
31. Doetschman T, Eistetter H, Katz M, Schmidt W, Kemler R (1985) The in vitro
development of blastocyst-derived embryonic stem cell lines: formation of
visceral yolk sac, blood islands and myocardium. Development 87: 27.
32. O’Shea K (2004) Self-renewal vs. Differentiation of Mouse Embryonic Stem
Cells 1. Biology of Reproduction: Soc Study Reprod. pp 1755–1765.
33. Rathjen J, Rathjen P (2001) Mouse ES cells: experimental exploitation of
pluripotent differentiation potential. Current Opinion in Genetics & Develop-
ment 11: 587–594.
34. Willems E, Leyns L (2008) Patterning of mouse embryonic stem cell-derived
pan-mesoderm by Activin A/Nodal and Bmp4 signaling requires Fibroblast
Growth Factor activity. Differentiation 76: 745.
35. Morrison G, Oikonomopoulou I, Migueles R, Soneji S, Livigni A, et al. (2008)
Anterior Definitive Endoderm from ESCs Reveals a Role for FGF Signaling.
Cell Stem Cell 3: 402–415.
36. Pollard S, Wallbank R, Tomlinson S, Grotewold L, Smith A (2008) Fibroblast
growth factor induces a neural stem cell phenotype in foetal forebrain
progenitors and during embryonic stem cell differentiation. Molecular and
Cellular Neuroscience 38: 393–403.
37. Lake J, Rathjen J, Remiszewski J, Rathjen P (2000) Reversible programming of
pluripotent cell differentiation. Journal of Cell Science 113: 555.
38. Rathjen J, Lake J, Bettess M, Washington J, Chapman G, et al. (1999)
Formation of a primitive ectoderm like cell population, EPL cells, from ES cells
in response to biologically derived factors. Journal of Cell Science 112: 601.
39. Pelton T, Sharma S, Schulz T, Rathjen J, Rathjen P (2002) Transient
pluripotent cell populations during primitive ectoderm formation: correlation of
in vivo and in vitro pluripotent cell development. Journal of Cell Science 115:
329–339.
40. Maye P, Becker S, Kasameyer E, Byrd N, Grabel L (2000) Indian hedgehog
signaling in extraembryonic endoderm and ectoderm differentiation in ES
embryoid bodies. Mechanisms of Development 94: 117–132.
41. Hughes J, Washington J, Zheng Z, Lau X, Yap C, et al. (2009) Manipulation of
Cell: Cell Contacts and Mesoderm Suppressing Activity Direct Lineage Choice
from Pluripotent Primitive Ectoderm-Like Cells in Culture. PLoS ONE 4:
e5579. doi: 10.1371/journal.pone.0005579.
42. Hughes J, Dodge N, Rathjen P, Rathjen J (2009) A Novel Role for gamma-
Secretase in the Formation of Primitive Streak-like Intermediates from ES Cells
in Culture. Stem cells 27: 2941–2951.
43. Orr-Urtreger A, Givol D, Yayon A, Yarden Y, Lonai P (1991) Developmental
expression of two murine fibroblast growth factor receptors, flg and bek.
Development 113: 1419.
44. Mohammadi M, Froum S, Hamby J, Schroeder M, Panek R, et al. (1998)
Crystal structure of an angiogenesis inhibitor bound to the FGF receptor
tyrosine kinase domain. The EMBO Journal 17: 5896.
45. Kunii K, Davis L, Gorenstein J, Hatch H, Yashiro M, et al. (2008) FGFR2-
amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for
growth and survival. Cancer Research 68: 2340.
46. Trudel S, Ely S, Farooqi Y, Affer M, Robbiani D, et al. (2004) Inhibition of
fibroblast growth factor receptor 3 induces differentiation and apoptosis in t (4;
14) myeloma. Blood 103: 3521.
47. Ezzat S, Huang P, Dackiw A, Asa S (2005) Dual inhibition of RET and FGFR4
restrains medullary thyroid cancer cell growth. Clinical cancer research 11:
1336.
48. Schulte-Merker S, Smith J (1995) Mesoderm formation in response to Brachyury
requires FGF signalling. Current Biology 5: 62–67.
49. LaBonne C, Whitman M (1994) Mesoderm induction by activin requires FGF-
mediated intracellular signals. Development 120: 463–472.
50. Cornell R, Kimelman D (1994) Activin-mediated mesoderm induction requires
FGF. Development 120: 453–462.
51. Johansson B, Wiles M (1995) Evidence for involvement of activin A and bone
morphogenetic protein 4 in mammalian mesoderm and hematopoietic
development. Molecular and Cellular Biology 15: 141–151.
52. Pick M, Azzola L, Mossman A, Stanley E, Elefanty A (2007) Differentiation of
human embryonic stem cells in serum-free medium reveals distinct roles for
bone morphogenetic protein 4, vascular endothelial growth factor, stem cell
factor, and fibroblast growth factor 2 in hematopoiesis. Stem Cells 25: 2206.
53. Bhardwaj G, Murdoch B, Wu D, Baker D, Williams K, et al. (2001) Sonic
hedgehog induces the proliferation of primitive human hematopoietic cells via
BMP regulation. Nature Immunology 2: 172–180.
54. Sadlon T, Lewis I, D’Andrea R (2004) BMP4: Its Role in Development of the
Hematopoietic System and Potential as a Hematopoietic Growth Factor. Stem
Cells 22: 457–474.
55. Xu R, Peck R, Li D, Feng X, Ludwig T, et al. (2005) Basic FGF and suppression
of BMP signaling sustain undifferentiated proliferation of human ES cells.
Nature Methods 2: 185–190.
56. Bendall S, Stewart M, Menendez P, George D, Vijayaragavan K, et al. (2007)
IGF and FGF cooperatively establish the regulatory stem cell niche of
pluripotent human cells in vitro. Nature 448: 1015–1021.
57. Vallier L, Alexander M, Pedersen R (2005) Activin/Nodal and FGF pathways
cooperate to maintain pluripotency of human embryonic stem cells. Journal of
Cell Science 118: 4495.
58. Kunath T, Saba-El-Leil M, Almousailleakh M, Wray J, Meloche S, et al. (2007)
FGF stimulation of the Erk1/2 signalling cascade triggers transition of
pluripotent embryonic stem cells from self-renewal to lineage commitment.
Development 134: 2895.
59. Thomas P, Beddington R (1996) Anterior primitive endoderm may be
responsible for patterning the anterior neural plate in the mouse embryo.
Current Biology 6: 1487–1496.
60. Wang L, Li L, Menendez P, Cerdan C, Bhatia M (2005) Human embryonic
stem cells maintained in the absence of mouse embryonic fibroblasts or
conditioned media are capable of hematopoietic development. Blood 105:
4598–4603.
61. Xu C, Rosler E, Jiang J, Lebkowski J, Gold J, et al. (2005) Basic fibroblast growth
factor supports undifferentiated human embryonic stem cell growth without
conditioned medium. Stem Cells 23: 315–323.
62. Amit M, Carpenter M, Inokuma M, Chiu C, Harris C, et al. (2000) Clonally
derived human embryonic stem cell lines maintain pluripotency and proliferative
potential for prolonged periods of culture. Developmental Biology 227: 271–278.
63. Ying Q, Stavridis M, Griffiths D, Li M, Smith A (2003) Conversion of
embryonic stem cells into neuroectodermal precursors in adherent monoculture.
Nature biotechnology 21: 183–186.
64. Era T, Izumi N, Hayashi M, Tada S, Nishikawa S, et al. (2007) Multiple
mesoderm subsets give rise to endothelial cells, whereas hematopoietic cells are
differentiated only from a restricted subset in embryonic stem cell differentiation
culture. Stem Cells 26: 401–411.
65. Yamanaka Y, Lanner F, Rossant J (2010) FGF signal-dependent segregation of
primitive endoderm and epiblast in the mouse blastocyst. Development 137:
715.
FGFs in Gastrulation
PLoS ONE | www.plosone.org 12 September 2010 | Volume 5 | Issue 9 | e1255566. Greber B, Wu G, Bernemann C, Joo J, Han D, et al. (2010) Conserved and
Divergent Roles of FGF Signaling in Mouse Epiblast Stem Cells and Human
Embryonic Stem Cells. Cell Stem Cell 6: 215–226.
67. McAvoy J, Chamberlain C (1989) Fibroblast growth factor (FGF) induces
different responses in lens epithelial cells depending on its concentration.
Development 107: 221–228.
68. Schulz M, Chamberlain C, de Iongh R, McAvoy J (1993) Acidic and basic FGF
in ocular media and lens: implications for lens polarity and growth patterns.
Development 118: 117–126.
69. Rathjen J, Rathjen P (2003) Lineage specific differentiation of mouse ES cells:
Formation and differentiation of early primitive ectoderm-like(EPL) cells.
Methods in enzymology 365: 3–25.
70. Rathjen J, Haines B, Hudson K, Nesci A, Dunn S, et al. (2002) Directed
differentiation of pluripotent cells to neural lineages: homogeneous formation
and differentiation of a neurectoderm population. Development 129:
2649–2661.
71. Simon P (2003) Q-Gene: processing quantitative real-time RT-PCR data.
Bioinformatics 19: 1439–1440.
72. Muller P, Janovjak H, Miserez A, Dobbie Z (2002) Processing of gene expression
data generated by quantitative real-time RT-PCR. Biotechniques 32:
1372–1379.
FGFs in Gastrulation
PLoS ONE | www.plosone.org 13 September 2010 | Volume 5 | Issue 9 | e12555